Zai Lab Limited Share Price Hong Kong S.E.
Stocks
9688
KYG9887T1168
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Hong Kong S.E.
01:38:17 13/11/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 20.24 HKD | -3.71% |
|
+10.24% | +48.28% |
| 13/11 | Zai Lab Limited - Special Call | |
| 13/11 | Zai Lab Says Experimental Drug Reduced Activity of Protein Linked to Atopic Dermatitis by at Least 90% | MT |
| Market Cap | 276.61Cr 2.17TCr 250.67Cr 231.85Cr 209.19Cr 394.22Cr 26TCr 408.12Cr 2.79TCr 1.1TCr 14TCr 1.04TCr 1.02TCr 44TCr | P/E 2026 * |
-13.2x | P/E 2027 * | -11.5x |
|---|---|---|---|---|---|
| Enterprise Value | 212.74Cr 1.67TCr 192.79Cr 178.32Cr 160.89Cr 303.19Cr 20TCr 313.88Cr 2.14TCr 849.37Cr 11TCr 798.36Cr 781.42Cr 34TCr | EV / Sales 2026 * |
4.84x | EV / Sales 2027 * | 4.26x |
| Free-Float |
93.88% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 9688 | Delayed | |
Tradegate
| 1ZLB | Real-time | |
|
Deutsche Boerse AG
| 1ZLB | Delayed | |
|
Boerse Muenchen
| 1ZLB | Real-time | |
|
Börse Stuttgart
| 1ZLB | Delayed |
Last Transcript: Zai Lab Limited
| 1 day | -3.71% | ||
| 1 week | +10.24% | ||
| Current month | +16.52% | ||
| 1 month | +15.79% | ||
| 3 months | +0.70% | ||
| 6 months | +31.86% | ||
| Current year | +48.28% |
| 1 week | 19.89 |  | 21.5 |
| 1 month | 16.57 | | 21.5 |
| Current year | 12.31 | | 21.5 |
| 1 year | 12.31 | | 21.5 |
| 3 years | 10.56 | | 35.5 |
| 5 years | 10.56 | | 72 |
| 10 years | 10.56 | | 151.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ying Du
CEO | Chief Executive Officer | 61 | 01/04/2014 |
Ya jing Chen
DFI | Director of Finance/CFO | 58 | 07/07/2023 |
Rafael Amado
PSD | President | 62 | 01/12/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ying Du
CHM | Chairman | 61 | 01/04/2014 |
John Diekman
BRD | Director/Board Member | 83 | 01/01/2017 |
Peter Wirth
BRD | Director/Board Member | 75 | 01/01/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.71% | +10.24% | - | - | 276.61Cr | |
| +1.26% | +6.61% | +40.79% | +136.32% | 1,28600Cr | |
| +0.79% | +3.45% | +45.84% | +93.52% | 69TCr | |
| +0.20% | +1.28% | +26.97% | +113.70% | 52TCr | |
| -0.44% | +3.69% | +41.45% | +68.91% | 39TCr | |
| +0.55% | +0.70% | +59.02% | +44.62% | 36TCr | |
| -0.12% | +0.74% | +28.39% | +58.54% | 30TCr | |
| +0.37% | +0.37% | +3.33% | +37.27% | 29TCr | |
| -0.30% | +1.14% | +38.29% | +72.46% | 25TCr | |
| +0.08% | +0.71% | +34.44% | +124.95% | 21TCr | |
| Average | -0.13% | +2.08% | +35.39% | +83.36% | 48TCr | |
| Weighted average by Cap. | +0.54% | +3.26% | +37.70% | +96.50% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 44Cr 344.52Cr 40Cr 37Cr 33Cr 63Cr 4.14TCr 65Cr 442.16Cr 175.32Cr 2.21TCr 164.79Cr 161.3Cr 7.02TCr | 54Cr 421.72Cr 49Cr 45Cr 41Cr 77Cr 5.07TCr 79Cr 541.24Cr 214.61Cr 2.71TCr 201.72Cr 197.44Cr 8.59TCr |
| Net income | -21Cr -167.48Cr -19Cr -18Cr -16Cr -30Cr -2.01TCr -31Cr -214.95Cr -85Cr -1.08TCr -80Cr -78Cr -3.41TCr | -22Cr -171.18Cr -20Cr -18Cr -17Cr -31Cr -2.06TCr -32Cr -219.69Cr -87Cr -1.1TCr -82Cr -80Cr -3.49TCr |
| Net Debt | -64Cr -501.11Cr -58Cr -54Cr -48Cr -91Cr -6.02TCr -94Cr -643.12Cr -255.01Cr -3.22TCr -239.69Cr -234.61Cr -10TCr | -47Cr -371.77Cr -43Cr -40Cr -36Cr -68Cr -4.47TCr -70Cr -477.12Cr -189.19Cr -2.39TCr -177.83Cr -174.05Cr -7.58TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/26/13 | HK$20.24 | -3.71% | 34,43,000 |
| 12/26/12 | HK$21.02 | +2.74% | 48,26,400 |
| 11/26/11 | HK$20.46 | -4.75% | 42,65,500 |
| 10/26/10 | HK$21.48 | +2.48% | 70,42,800 |
| 09/26/09 | HK$20.96 | +14.16% | 1,02,26,265 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- ZLAB Stock
- 9688 Stock
Select your edition
All financial news and data tailored to specific country editions
